Medical Fiction: Darko and Toaster Tim – A Dance With the Devil
This is one of a collection of stories that are like “Final Destination” meets “The Monkey’s Paw”...
Rheumatology Newsletter
The Bidirectional Association Between Psoriasis & OSA
With psoriasis and obstructive sleep apnea (OSA) sharing various comorbidities and having a common...
Amenorrhea & Bone Mineral Density in Women With HIV
Although previous studies indicate that HIV is a risk factor for missed menstrual periods, or...
FDA Names Remdesivir First Approved Covid-19 Tx
Much-touted antiviral drug gains full approval following EUA WASHINGTON — The FDA granted full...
Genetic Variants Linked to Severe Covid-19
Genome-wide association study identifies ABO blood protein The identification of a gene cluster...
Covid-19: Johnson & Johnson Vax Trial Paused
’Unexplained illness’ in one participant Johnson & Johnson paused all of its Covid-19 vaccine...
NEJM Editors Blast Trump Administration’s Covid-19 Response
Storied journal stops short of endorsing a candidate For the first time in its more than 200-year...
Covid-19: Remdesivir Shortens Recovery Time in ACTT-1 Study
Hydroxychloroquine shows no benefit in RECOVERY trial A 10-day course of the antiviral drug...
Loneliness in the Children during the times of Covid 19
The children these days are already suffering a life of so much pain and anguish. People these...
Risk for Infection with Low-Dose Glucocorticoids in Patients having Rheumatoid Arthritis
Patients with rheumatoid arthritis (RA) and other chronic conditions frequently receive low-dose glucocorticoids (GCs) as bridging therapy when starting or changing disease-modifying antirheumatic drug (DMARD) treatment....
Can Turmeric Extract Spice Up OA Treatment?
Extract proved effective in managing knee pain but made no mark on effusion-synovitis A randomized, double-blind, placebo-controlled trial found that extract from the curcuma longa (CL) plant — or turmeric, as it’s...
Is Belimumab as Add-On to Standard Tx for Lupus Nephritis Effective, Safe?
Results of the BLISS-52 study are promising, but several caveats remain The addition of belimumab—a recombinant human IgG-1ʎ monoclonal antibody—to standard treatment for lupus nephritis may improve renal...
